Skip to main content
    R

    Rezolute Inc (RZLT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.58
    -0.08 (-2.05%)

    Market Cap: $353.54M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Rezolute Inc (RZLT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Rezolute (RZLT) to earn -$0.67 per share in the fiscal year ending Jun 30, 2027, on revenue of $2.09M. Of 11 analysts, 11 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 6 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 1.82, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy218.2%
    Buy981.8%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    11

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 2541.1%.

    Fiscal year ending Jun 30, 2027
    -$0.67
    EPS consensus, revenue $2.09M
    Fiscal year ending Jun 30, 2028
    -$0.44
    EPS consensus, revenue $55.20M
    Next report
    Feb 10, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Jun 30, 2027-$0.67-$0.74 to -$0.608$2.09MN/A11
    Jun 30, 2028-$0.44-$0.80 to -$0.158$55.20M$3.86M to $186.25M11

    Quarterly Estimates

    Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Jun 30, 2027, at -$0.18, and highest for the quarter ending Dec 31, 2026, at -$0.17.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.17-$0.19 to -$0.148
    Mar 31, 2027-$0.17-$0.20 to -$0.138
    Jun 30, 2027-$0.18-$0.22 to -$0.1313

    Estimate Revisions

    Across the 4 periods below, the last 30 days brought 2 upward and 16 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Jun 30, 202716
    Fiscal year ending Jun 30, 202813
    Quarter ending Dec 31, 202604
    Quarter ending Mar 31, 202703

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Jun 30, 2027 has worsened from -$0.63.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Jun 30, 2027-$0.67-$0.70-$0.70-$0.63-$0.63N/A
    Fiscal year ending Jun 30, 2028-$0.44-$0.47-$0.47-$0.28-$0.28N/A
    Quarter ending Dec 31, 2026-$0.17-$0.17-$0.17-$0.13-$0.13N/A
    Quarter ending Mar 31, 2027-$0.17-$0.18-$0.18-$0.14-$0.14N/A

    Frequently Asked Questions About RZLT

    What is the RZLT stock forecast?

    Consensus analyst estimates put Rezolute's EPS at -$0.67 for the fiscal year ending Jun 30, 2027, on revenue of $2.09M. The consensus rating from 11 analysts is Buy.

    How do analysts rate RZLT stock?

    Of 11 analysts covering Rezolute, 2 rate it Strong Buy, 9 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from RZLT next year?

    For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$0.67, with estimates from -$0.74 to -$0.60 from 8 analysts. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$0.44, with estimates from -$0.80 to -$0.15 from 8 analysts.

    What revenue do analysts expect from Rezolute next year?

    For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $2.09M. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $55.20M, with estimates from $3.86M to $186.25M.

    How many analysts cover RZLT?

    11 analysts rate Rezolute stock, and 8 analysts estimate its EPS for the fiscal year ending Jun 30, 2027.